In humans, EGFR is frequently overexpressed in 50–81% of NSCLC and such overexpression has been demonstrated to be associated with cancer susceptibility, metastasis, survival prognosis and chemotherapy response (7–14). This evidence concerns the gene EGFR and cancer.